UCSD is the first hospital to offer vMap arrhythmia mapping software


Vektor Medical has announced that the University of California, San Diego Health (UCSD, San Diego, USA) is the first hospital system to offer the vMap arrhythmia mapping system.

The recently US Food and Drug Administration (FDA)-approved technology identifies potential arrhythmia source locations using only 12-lead electrocardiogram (ECG) data. The company is rolling out the technology at select cardiovascular centres of excellence across the country over the coming year before making it more widely available.

vMap is designed to quickly, easily, and non-invasively map arrhythmia sources associated with stable or unstable arrhythmias in all four chambers of the heart, the septal wall, and the outflow tracts. The system has demonstrated success in identifying arrhythmia sources for a wide variety of arrhythmias, including atrial fibrillation (AF).

“Ablation procedures are not as effective as they could be today because traditional mapping can be imprecise and complex,” said Mike Monko, CEO of Vektor Medical. “Our mission is to improve outcomes in cardiac arrhythmia care, and we are excited to be able to introduce the unique benefits of vMap to the clinical community, starting with UCSD. UCSD operates a state-of-the-art electrophysiology laboratory and operating room and treats hundreds of patients with arrhythmias each year.”

“We are committed to providing the most advanced cardiac arrhythmia care for our patients and are enthusiastic about the opportunity to improve the efficacy and safety of the ablations at UCSD using vMap,” said Farshad Raissi, associate professor of medicine at UCSD. “We anticipate that vMap’s non-invasive arrhythmia source mapping will enable our team to accurately identify and quickly target arrhythmia sources, which we hope will minimise the need for repeat procedures and reduce risk for patients.”

vMap was invented by physicians and engineers currently on staff at UCSD, who co-founded Vektor Medical to develop and commercialise the technology, including David Krummen, Gordon Ho and Andrew McCulloch. The company’s chief technology officer, Chris Villongco, is also a co-founder and earned his doctorate at UCSD.


Please enter your comment!
Please enter your name here